Besides the co-amplification with ERBB2 in breast cancer, the SRCIN1 gene might be lost or disrupted in some cases of aggressive neuroblastoma due to the 17q12 chromosomal rearrangement (Grasso et al., 2020). This evidence concerns the gene ERBB2 and breast carcinoma.